The Trinity Guardion Patient Protection System™ Proven to Reduce Hospital-Acquired Infections by 50 Percent

CINCINNATI--()--A recent study published in the American Journal of Infection Control found that in a clinical trial, Trinity Guardion’s launderable barrier bed cover was proven to reduce hospital-acquired infections such as Clostridium difficile (C. diff) by 50 percent.

Led by Edmond Hooker, MD, associate professor in Health Services Administration at Xavier University, along with Mark Bochan, MD, an infectious disease physician with Infectious Disease of Indiana, the trial was conducted at St. Vincent Seton Specialty Hospital in Indianapolis and St. Vincent Seton Specialty Hospital in Lafayette, IN, over the course of 14 months.

“We compared infection rates before and after these two hospitals began using the bed cover system and discovered that by following the handling and washing instructions, the infection rates were cut in half,” said Dr. Hooker.

According to data from the Centers for Disease Control and Prevention (CDC), there are approximately 500,000 C. diff infections each year in the U.S., causing patients to suffer from an inflamed colon, abdominal pain, severe diarrhea and, in some cases, death. Other CDC studies indicate that “C. difficile has become the most common microbial cause of healthcare-associated infections in U.S. hospitals and costs up to $4.8 billion each year in excess health care costs for acute care facilities alone.”

“Hospital-acquired infections like C. diff are difficult to treat and easily transmitted,” said Ardis Dee Hoven, MD, an internal medicine and infectious disease specialist, former president of the American Medical Association and current Trinity Guardion board member. “However, new technology such as Trinity Guardion’s bed protection system is truly a breakthrough and will help to control, and hopefully reduce, C. diff rates significantly across the U.S.”

The world’s first and only patented and launderable bed protection system contains an anti-microbial and works by protecting the mattress and bed deck from bacteria that can cause serious infections such as C. diff. The system is designed to be laundered using high heat and chlorine bleach to kill off spores and can stand up to more than 100 washings and still maintain its protection rate.

“This study calls into question the efficacy of disinfectants on both hard and soft surfaces,” said Bruce Rippe, CEO and co-founder of Trinity Guardion. “Soft surface cleaners cannot kill 100 percent of bacteria and they can also seep through mattress covers and into crevices. Hard surface cleaners are not effective on soft surfaces and are very harmful to the mattress. As a result, bacterial spores can lie dormant on these soft surfaces, such as a hospital bed mattress, for months. These spores can become infectious after ingestion. In addition, hospital mattresses are the highest patient touch point and the most soiled medical device with a very weak disinfection process.”

About Trinity Guardion

Founded in 2010 and based in Batesville, IN, Trinity Guardion manufactures the world’s only launderable bed cover system and pillow cases for hospital beds and bed decks that is specifically engineered to eliminate bacteria such as Clostridium difficile (C. diff). The Trinity Bed System Protection System™, resulting from collaboration of international scientists, physicians and academic professionals, delivers a level of bed cleanliness previously unseen in the healthcare industry for hospital beds.

Contacts

Trinity Guardion
Libby Esterle, 513-324-5033
libby@rasormarketing.com

Release Summary

A recent study published in the American Journal of Infection Control found that in a clinical trial Trinity Guardion’s launderable barrier bed cover was proven to reduce hospital-acquired infections.

Contacts

Trinity Guardion
Libby Esterle, 513-324-5033
libby@rasormarketing.com